8-Azapurines as new inhibitors of cyclin-dependent kinases
- 15 September 2005
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 13 (18), 5399-5407
- https://doi.org/10.1016/j.bmc.2005.06.007
Abstract
No abstract availableKeywords
Funding Information
- Advanced Scientific Computing Research (301/05/0418)
- Ministerstvo Školství, Mládeže a Tělovýchovy
- Grantová Agentura České Republiky (MSM 6198959216)
This publication has 29 references indexed in Scilit:
- Unmasking the S-Phase-Promoting Potential of Cyclin B1Science, 2003
- Cdk2 dethroned as master of S phase entryCancer Cell, 2003
- Proliferation of cancer cells despite CDK2 inhibitionCancer Cell, 2003
- Complexities in the development of cyclin-dependent kinase inhibitor drugsTrends in Molecular Medicine, 2002
- Cyclin-Dependent Kinase Inhibitors: Useful Targets in Cell Cycle RegulationJournal of Medicinal Chemistry, 2000
- Tossing monkey wrenches into the clock: New ways of treating cancerProceedings of the National Academy of Sciences of the United States of America, 1999
- Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonistsProceedings of the National Academy of Sciences of the United States of America, 1999
- Exploiting Chemical Libraries, Structure, and Genomics in the Search for Kinase InhibitorsScience, 1998
- Cytokinin-Derived Cyclin-Dependent Kinase Inhibitors: Synthesis and cdc2 Inhibitory Activity of Olomoucine and Related CompoundsJournal of Medicinal Chemistry, 1997
- Inhibition of Cyclin‐Dependent Kinases by Purine AnaloguesJBIC Journal of Biological Inorganic Chemistry, 1994